Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 1/20 | 0.35 |
| ▸ | NCOA1 | Q15788 | 2/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | NCF1 | P14598 | 1/20 | 0.33 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28730172 | 0.98 | MAPT (0.47) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL5937225 | 0.86 | MAPT (0.44) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL30081188 | 0.80 | KDM4E (0.39) | MAPTKDM4ESMN1; SMN2ERN1ADRB2 | |
| SCHEMBL5736513 | 0.77 | MAPT (0.42) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL208503 | 0.77 | MAPT (0.48) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL10339659 | 0.75 | MAPT (0.43) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL29639994 | 0.74 | ALDH1A1 (0.39) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL17529294 | 0.73 | MAPT (0.48) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL1644904 | 0.73 | LMNA (0.48) | MAPTKDM4ECYP3A4LMNAHIF1A | |
| SCHEMBL13791237 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240155939-A1 | HETEROCYCLIC AROMATIC AMINE COMPOUND AND ELECTROLUMINESCENCE USING THE SAME | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2024-05-09 | — | — | US | claimed |
| CN-112480112-B | Method for synthesizing substituted dihydrophenanthroline compound | 浙江工业大学 | 2021-10-15 | — | — | CN | claimed |
| CN-112480112-A | Method for synthesizing substituted dihydrophenanthroline compound | 浙江工业大学 | 2021-03-12 | — | — | CN | claimed |
| CN-102887915-A | Heteronuclear bimetallic complex light-emitting material and preparation method and application thereof | UNIV JIAYING | 2013-01-23 | — | — | CN | claimed |
| JP-2005523717-A | — | — | 2005-08-11 | — | — | JP | claimed |
| EP-1499705-A2 | MICROFERMENTORS FOR RAPID SCREENING AND ANALYSIS OF BIOCHEMICAL PROCESSES | Massachusetts Institute of Technology (US) | 2005-01-26 | — | — | EP | claimed |
| WO-2003093406-A2 | MICROFERMENTORS FOR RAPID SCREENING AND ANALYSIS OF BIOCHEMICAL PROCESSES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2003-11-13 | — | — | WO | claimed |
| US-20250255096-A1 | LIGHT EMITTING DEVICE AND LIGHT EMITTING DISPLAY DEVICE | LG DISPLAY CO., LTD. (KR) | 2025-08-07 | — | — | US | disclosed |
| CN-111138463-B | Organic electroluminescent device and polycyclic compound for organic electroluminescent device | 三星显示有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-118895063-A | Ink composition and display device | 三星显示有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-118580208-A | Light-emitting element and amine compound for light-emitting element | 三星显示有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118290453-A | Light-emitting element and condensed polycyclic compound for light-emitting element | 三星显示有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20240155939-A1 | HETEROCYCLIC AROMATIC AMINE COMPOUND AND ELECTROLUMINESCENCE USING THE SAME | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2024-05-09 | — | — | US | disclosed |
| US-5026828-A | Releasing undesired proteins, followed by releasing hepatitis B; diafiltration | MERCK & CO., INC. (US) | 1991-06-25 | — | — | US | disclosed |
| US-5011915-A | Centrifuging yeast membrane extract, then diafiltation in guanidine hydrochloride solution, solubilizing with denaturing agent and reducing agent | MERCK & CO., INC. (US) | 1991-04-30 | — | — | US | disclosed |
| EP-0340837-A1 | Recombinant GAG precursor of HIV, product, process, and use as aids vaccine | MERCK & CO. INC. (US) | 1989-11-08 | — | — | EP | disclosed |
| EP-0315242-A2 | Process for purifying recombinant hepatitis antigens | MERCK & CO. INC. (US) | 1989-05-10 | — | — | EP | disclosed |
| EP-0314240-A2 | Process for purifying recombinant hepatitis antigens | MERCK & CO. INC. (US) | 1989-05-03 | — | — | EP | disclosed |
| EP-0312164-A1 | Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells | MERCK & CO. INC. (US) | 1989-04-19 | — | — | EP | disclosed |
| EP-0280470-A1 | Method of purifying recombinant pres-1/S-2/S hepatitis B antigen from yeast | MERCK & CO. INC. (US) | 1988-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240155939-A1 | HETEROCYCLIC AROMATIC AMINE COMPOUND AND ELECTROLUMINESCENCE USING THE SAME | CCNL2, CHRM1, AHR | MAPT 4173/4885KDM4E 2787/4885CYP3A4 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.